Common variant in VEGFA and response to anti-VEGF therapy for neovascular age-related macular degeneration. - Wikidata - wikimedia - TriplyDB

Common variant in VEGFA and response to anti-VEGF therapy for neovascular age-related macular degeneration.

Common variant in VEGFA and response to anti-VEGF therapy for neovascular age-related macular degeneration.

http://www.wikidata.org/entity/Q37246901

about

Advances in the genomics of common eye diseases HIGH-DOSE HIGH-FREQUENCY AFLIBERCEPT FOR RECALCITRANT NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.The Immune System and AMD Bevacizumab treatment for neovascular age-related macular degeneration in the setting of a clinic: "real life" long-term outcome A genetic variant in NRP1 is associated with worse response to ranibizumab treatment in neovascular age-related macular degeneration.A prospective multicenter study on genome wide associations to ranibizumab treatment outcome for age-related macular degeneration.Clinical pharmacology of intravitreal anti-VEGF drugs.Exploring the Use of Molecular Biomarkers for Precision Medicine in Age-Related Macular Degeneration.Three Variants of or near VEGF-A Gene are Not Associated with Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy in a Han Chinese Population.Uncovering genetic and non-genetic biomarkers specific for exudative age-related macular degeneration: significant association of twelve variants.

P2860

Q27008236-6667B1A9-74F1-42F7-BD30-AC1348D83DFD Q30491978-17AC1910-8D7D-4875-A6AB-456AFD1F2539 Q34003743-F69B8666-D51C-4BC5-93B4-411A0ECF9D2E Q35503206-3C790BE7-4EDD-490A-954E-BD5CA72C53F5 Q36961818-CA29645F-36E1-4018-9B11-290C8CB21D1A Q41504310-415A6E9C-6388-45AE-8AD1-EC0617BE19CC Q48109878-2BD12ECD-6627-4A8E-8684-84D18EC71848 Q52559837-BC8FAE35-4F7A-44B0-BC10-E4A9FDE8AF84 Q54233123-5B956E9A-0694-43BE-A8F3-455747A7C531 Q54965254-06EA9B11-4914-43E3-9C1E-CC4C57A0782B

P2860

Common variant in VEGFA and response to anti-VEGF therapy for neovascular age-related macular degeneration.

http://www.wikidata.org/entity/Q37246901

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on July 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Common variant in VEGFA and re ...... -related macular degeneration.

@en

Common variant in VEGFA and re ...... -related macular degeneration.

@nl

type

label

Common variant in VEGFA and re ...... -related macular degeneration.

@en

Common variant in VEGFA and re ...... -related macular degeneration.

@nl

prefLabel

Common variant in VEGFA and re ...... -related macular degeneration.

@en

Common variant in VEGFA and re ...... -related macular degeneration.

@nl

P1433

Q37246901-95CDCE5D-AC1B-42A8-A21A-A5BD3EF47E06

P1476

Q37246901-EF855ABC-413F-41F0-B634-F6D10FAE9B54

P2093

Q37246901-0F658394-D1ED-4137-8FCD-C9C8B0F5C22C

Q37246901-0FF54607-1008-4E22-8405-29A3CF17C95E

Q37246901-1B9B591D-3236-48F1-B513-2F9106EA4356

Q37246901-361001D6-AA38-487B-9548-4998411126A7

Q37246901-48517A75-B3AE-41A0-89F9-6D9E5814C6B9

Q37246901-4F981F7C-0484-43BA-B4FA-68E27F8678D5

Q37246901-736A2C77-A5DA-45F0-AD39-CD17232D1891

Q37246901-9EB2A5CE-F3D9-409B-B4DD-732C183BDBBC

Q37246901-A11E14DD-4798-40D1-84EC-3DE2173475AA

Q37246901-A1CA39BD-B847-4C03-A288-BB3C6ECC629E

P2860

Q37246901-018620BA-57A2-4273-8F67-E0E862736B14

Q37246901-0D360182-A5AD-4019-B9B8-52F852B32C28

Q37246901-1D1BDE16-AC3A-40E2-9421-0487DF49992F

Q37246901-1FF440A9-85B8-41EB-8A7D-94EF5AD02620

Q37246901-41009E5C-ABE7-405E-AC9D-499D7514D5EB

Q37246901-45A4DD7C-2247-4D64-BF21-3523E881873C

Q37246901-46084777-B2F1-48A5-9029-AB16D0AC3C49

Q37246901-46CE9BD6-0DB7-4716-B429-946C8D7FCC60

Q37246901-5E54127C-4743-4911-9A8A-4C75B3F71E4D

Q37246901-5F30D160-D80E-4BC8-B56E-9ABC849FD498

P304

Q37246901-387A600D-3FA2-4547-9EBC-5E9B79AA24ED

P31

Q37246901-E5DFF442-49FA-4C5F-9097-840620F2EB96

P356

Q37246901-C6520184-92CA-49D5-ADB3-91157916F44D

P433

Q37246901-11DBBA90-0881-4CD9-8995-EF2CA73F750B

P478

Q37246901-C9A1BE60-7EE4-427A-AD9D-AFF1BAD2C571

P577

Q37246901-6B481E4A-E9F2-4A72-A5F8-727D8E484ECC

P698

Q37246901-CF4C6C8B-6EA1-4199-B716-B5AEA8DAA4C8

P932

Q37246901-BD469DC8-8871-42CB-85D0-BF45FE7A81F0

P356

15665240113139990048

P1433

Current Molecular Medicine

P1476

Common variant in VEGFA and re ...... -related macular degeneration.

@en

P2093

A Kimura

http://www.w3.org/2001/XMLSchema#string

D Pieramici

http://www.w3.org/2001/XMLSchema#string

G Cao

http://www.w3.org/2001/XMLSchema#string

H Ferreyra

http://www.w3.org/2001/XMLSchema#string

H Luo

http://www.w3.org/2001/XMLSchema#string

I Kozak

http://www.w3.org/2001/XMLSchema#string

J Lee

http://www.w3.org/2001/XMLSchema#string

J Quach

http://www.w3.org/2001/XMLSchema#string

K Zhang

http://www.w3.org/2001/XMLSchema#string

L Zhao

http://www.w3.org/2001/XMLSchema#string

P2860

Ranibizumab and bevacizumab for neovascular age-related macular degeneration

Ranibizumab for neovascular age-related macular degeneration

A prospective study on intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration of different durations.

Age-related macular degeneration: genetic and environmental factors of disease

Ranibizumab versus verteporfin for neovascular age-related macular degeneration.

Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to intravitreal bevacizumab.

Prevalence of age-related macular degeneration in old persons: Age, Gene/environment Susceptibility Reykjavik Study.

Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration.

Unraveling a multifactorial late-onset disease: from genetic susceptibility to disease mechanisms for age-related macular degeneration.

Review of genetics in age related macular degeneration.

P304

929-934

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/15665240113139990048

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2013-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23745581

http://www.w3.org/2001/XMLSchema#string

P932

3805052

http://www.w3.org/2001/XMLSchema#string